Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 76

Similar articles for PubMed (Select 23320053)

1.

Supportive therapy in medical therapy of head and neck tumors.

Link H.

GMS Curr Top Otorhinolaryngol Head Neck Surg. 2012;11:Doc01. doi: 10.3205/cto000083. Epub 2012 Dec 20.

2.

[Supportive therapy in medical therapy of head and neck tumors].

Link H.

Laryngorhinootologie. 2012 Mar;91 Suppl 1:S151-75. doi: 10.1055/s-0031-1299720. Epub 2012 Mar 28. Review. German.

PMID:
22456916
3.

2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.

Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.

Ther Apher Dial. 2010 Jun;14(3):240-75. doi: 10.1111/j.1744-9987.2010.00836.x.

PMID:
20609178
4.

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.

Bokemeyer C, Aapro MS, Courdi A, Foubert J, Link H, Osterborg A, Repetto L, Soubeyran P; European Organisation for Research and Treatment of Cancer (EORTC) Taskforce for the Elderly.

Eur J Cancer. 2007 Jan;43(2):258-70. Epub 2006 Dec 19. Review.

PMID:
17182241
5.

[Prevention and treatment of febrile neutropenia].

Montemurro F, Gallicchio M, Aglietta M.

Tumori. 1997;83(2 Suppl):S15-9. Review. Italian.

PMID:
9235724
6.

Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial.

García-Carbonero R, Mayordomo JI, Tornamira MV, López-Brea M, Rueda A, Guillem V, Arcediano A, Yubero A, Ribera F, Gómez C, Trés A, Pérez-Gracia JL, Lumbreras C, Hornedo J, Cortés-Funes H, Paz-Ares L.

J Natl Cancer Inst. 2001 Jan 3;93(1):31-8.

7.
8.

[Bone marrow suppression--including guidelines for the appropriate use of G-CSF].

Watanabe T.

Gan To Kagaku Ryoho. 2003 Jun;30(6):755-9. Review. Japanese.

PMID:
12852340
9.

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.

Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, Kearney N, Lyman GH, Pettengell R, Tjan-Heijnen VC, Walewski J, Weber DC, Zielinski C; European Organisation for Research and Treatment of Cancer.

Eur J Cancer. 2011 Jan;47(1):8-32. doi: 10.1016/j.ejca.2010.10.013. Epub 2010 Nov 20.

PMID:
21095116
10.
14.
15.

Lack of benefit of granulocyte macrophage or granulocyte colony stimulating factor in patients with febrile neutropenia.

Siddiqui T, Burney IA, Kakepoto GN, Khurshid M, Salam A, Smego RA Jr.

J Pak Med Assoc. 2002 May;52(5):206-10.

16.
17.

High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008).

Verbeke N, Beguin Y, Wildiers H, Canon JL, Bries G, Bosly A, Van Belle S.

Support Care Cancer. 2012 Jan;20(1):23-8. doi: 10.1007/s00520-010-1045-0. Epub 2010 Nov 25.

PMID:
21107613
18.

Weekly epoetin alfa during adjuvant chemotherapy for breast cancer: effect on hemoglobin levels and quality of life.

Hudis CA, Vogel CL, Gralow JR, Williams D; Procrit Study Group.

Clin Breast Cancer. 2005 Jun;6(2):132-42.

PMID:
16001991
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk